Investor and buyer interest in behavioral healthcare programs remains robust, but they are becoming increasingly sophisticated in how they evaluate operations. Sellers and those seeking investment can expect in-depth conversations on financial performance, marketing practices, clinical outcomes, and growth opportunities as well as discussions on government reimbursement, telehealth strategy, and value-based care contracts. Preparing for due diligence in advance, even years before the process formally begins, can not only better prepare executives, but also help them align their organizations for long-term growth. Join us for this panel discussion in which the buyer and investor perspective will benefit all attendees, regardless of where they may be in their M&A and investment process.
This year’s panel with have three distinguished guests, a healthcare M&A advisor, a buyer, and a lender: Morris Estes of Capital One Healthcare, Dan Davidson with Galen Mental Health, and Kevin Taggart with Mertz Taggart. All the panelists have extensive backgrounds in behavioral health M&A and will provide the audience with different perspectives on what they are seeing in today’s market and some of the trends they expect for 2023.